Entity family

Browse drugs

Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.

10,506articles mentioning drugs

58,393drug mentions

9,496distinct drugs extracted

0%of mentions human-reviewed

Filter articles

JournalContent resourceEvidence policyAutomated confidence floorArticles per pageReset filters

“Reviewed + threshold” includes every confirmed correction plus unreviewed proposals at or above the selected model score.

View all 9,496 drugs on one page

Articles mentioning drugs

10,506 articles · page 532 of 876

PO:03:090 Thrombocytopenia in systemic lupus erythematosus: platelets to prognosis

lupusscimed · abstract · 2026-03-01 · 2 matching annotations

93.5%

rituximab antimalarials SLE lupus Thrombocytopenia Mohammed VI University Hospital

…d with other systemic manifestations, except in two cases where rituximab was required for refractory thrombocytopenia.Conclusions Thromb…

PO:04:102 From knee pain to systemic lupus erythematosus(SLE) with antiphospholipid syndrome(APS) .A New-onset SLE misdiagnosed as preeclampsia in third trimester

lupusscimed · abstract · 2026-03-01 · 2 matching annotations

98.8%

prednisolone SLE preeclampsia APS peripartum cardiomyopathy

…n section at 31 weeks. During 15 days prior to delivery she had prednisolone in her daily therapy for joint pain, which started recently.Aft…

PO:05:124 Assessment of fatigue and disease activity in patients with systemic lupus erythematosus

lupusscimed · abstract · 2026-03-01 · 2 matching annotations

96.0%

prednisone SLE SLE-DAS corticosteroid (CS) therapy CS therapy

….05). Among patients receiving CS, median FACIT-F scores across prednisone dose groups (<=5 mg, >5–<=10 mg, >10 mg) were 18, 30, and 30, r…

PO:05:125 Remission is associated with better health-related quality of life and work-force participation, with lower fatigue, and better patient-reported disease activity. Data from the almenara lupus cohort

lupusscimed · abstract · 2026-03-01 · 2 matching annotations

93.1%

prednisone Systemic lupus erythematosus SLE

…d no activity on a major organ, physician global assessment<=1, prednisone daily dose<=7.5mg/d, immunosuppressive drugs on maintenance dos…

PO:06:164 Integrated multi-system profiling reveals amplified prothrombotic pathway interactions during high disease activity in systemic lupus erythematosus

lupusscimed · abstract · 2026-03-01 · 2 matching annotations

98.7%

hydroxychloroquine glucocorticoids SLE systemic lupus erythematosus Danish ethics committee

…ria; 35% were persistently aPL positive. All patients initiated hydroxychloroquine ± glucocorticoids ± other immunosuppressants according to stand…

PO:06:166 Single cell RNA-seq defines distinct IgA1+ and IgA2+ B cell endotypes in systemic lupus erythematosus

lupusscimed · abstract · 2026-03-01 · 2 matching annotations

99.2%

belimumab rituximab SLE mucocutaneous disease

…ntibodies are associated with response to rituximab followed by belimumab. This study aimed to investigate IgA2+ B cells in SLE using 5’ …

PO:06:175 Single-cell RNA-seq reveals a persistent IFN signature in immune cells from SLE patients with high versus low polygenic risk scores despite HCQ treatment

lupusscimed · abstract · 2026-03-01 · 2 matching annotations

98.0%

prednisolone hydroxychloroquine systemic lupus erythematosus SLE

…AS) and treated with antimalarials only, and were not receiving prednisolone. We assessed differential gene expression, interferon (IFN) sig…

PO:07:182 Predicting work disability in systemic lupus erythematosus patients: a machine learning approach to guide early clinical intervention

lupusscimed · abstract · 2026-03-01 · 2 matching annotations

94.0%

glucocorticoids antimalarials Systemic lupus erythematosus Toronto Lupus Clinic SLE-mortality SLE

…sits to the clinic over longer follow-ups, with higher doses of glucocorticoids and antimalarials, higher disease activity, irreversible damage…

PO:07:190 HPV infection in systemic lupus erythematosus: frequency, cytological findings, and associated risk factors in a single-center cohort from a dedicated lupus clinic

lupusscimed · abstract · 2026-03-01 · 2 matching annotations

99.5%

cyclophosphamide SLE invasive squamous cell carcinoma university hospital HSIL anal intraepithelial neoplasia High-Grade Squamous Intraepithelial Lesions

…PV-positive; 55.5% with high-risk serotypes; 22.2% had received cyclophosphamide).One middle-aged woman developed stage IIIB squamous cell carci…

PO:07:195 A multicenter, real-world, cross-sectional study of cutaneous lupus erythematosus in the United States: clinical and demographic characteristics

lupusscimed · abstract · 2026-03-01 · 2 matching annotations

94.2%

antimalarials topical corticosteroids Cutaneous lupus erythematosus Biogen immunosuppressants systemic lupus erythematosus CLE Erythema CLA-IGA-R

… anxiety (13.9%). Participants’ current CLE treatments included antimalarials (69.7%), topical corticosteroids (50.8%), and immunosuppressant…

PO:08:204 Functional and rehabilitation aspects in postpartum women with systemic lupus erythematosus: an early multidisciplinary approach

lupusscimed · abstract · 2026-03-01 · 2 matching annotations

80.3%

SLEDAI SF-36 SLE systemic lupus erythematosus Short Form 36 Health Survey Jaccoud’s arthropathy

…s/minus 1.8) and correlated with HAQ-DI (r=0.72). Patients with SLEDAI greater than 6 reported greater exertion (16.2 plus/minus 1.9 v…

PO:08:213 Early vascular changes in a paediatric CTD cohort – results from LEAP

lupusscimed · abstract · 2026-03-01 · 2 matching annotations

89.3%

steroid Systemic Lupus Erythematosus Systemic Sclerosis dermatomyositis SLE tertiary paediatric centre uCTD DM JSLE JDM+1 more

…(n=6) were on biologics. 45% (n=11) were on steroid, making the steroid burden very high. The patients’ PWV was 6.7, compared to 6.5 in…